Frank O'Donnell
Chief Executive Officer bei INHIBITOR THERAPEUTICS, INC.
Vermögen: 3 500 $ am 31.03.2024
Profil
Frank E.
O'Donnell is the founder of BioDelivery Sciences International, Inc. (founded in 2000) and Hopkins Capital Group (founded in 1999).
He holds the title of Director at BioDelivery Sciences International, Inc. from 2018 to 2020 and was previously the Chief Executive Officer at Hopkins Capital Group.
Dr. O'Donnell was also the founder of Biotech Specialty Partners LLC, Repurposed Therapeutics, Inc., and RetinaPharma Technologies, Inc.
Dr. O'Donnell's current job(s) included being the Executive Chairman & Chief Executive Officer at Inhibitor Therapeutics, Inc. since 2022, Chairman at PhotoVision Pharmaceuticals, Inc., Chairman at Defender Pharmaceuticals, Inc., Trustee at St. Louis University, and Trustee at Health Careers Foundation.
Dr. O'Donnell's former job(s) include being the Chairman & Chief Executive Officer at Accentia Biopharmaceuticals, Inc. from 2002 to 2012, Executive Chairman at BioVest International, Inc. from 2012 to 2013, Executive Chairman at Inhibitor Therapeutics, Inc. from 2013 to 2016, and Chairman-Ophthalmology Department at Saint Louis University School of Medicine.
Dr. O'Donnell's education history includes undergraduate studies at The Johns Hopkins University School of Medicine.
Dr. O'Donnell is also the founder of Biotech Specialty Partners LLC, Repurposed Therapeutics, Inc., RetinaPharma Technologies, Inc...
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
29.03.2024 | 50 000 ( 0,03% ) | 3 500 $ | 31.03.2024 |
Aktive Positionen von Frank O'Donnell
Unternehmen | Position | Beginn |
---|---|---|
INHIBITOR THERAPEUTICS, INC. | Chief Executive Officer | 13.12.2022 |
Hopkins Capital Group
Hopkins Capital Group Investment ManagersFinance Hopkins Capital Group(Hopkins Capital) is a private equity firm founded in 1999 by Frank E. O'Donnell. The firm is headquartered in Tampa, Florida. | Chief Executive Officer | 01.01.1999 |
Health Careers Foundation | Director/Board Member | - |
PhotoVision Pharmaceuticals, Inc.
PhotoVision Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Photovision Pharmaceuticals, Inc. provides life sciences technology services. It offers medical instrument products. It focuses on drug development of deprenyl-based propargylamines and drug delivery carriers. The company is located in Rydal, PA. | Chairman | 08.06.2010 |
St. Louis University | Director/Board Member | 07.04.2011 |
Defender Pharmaceuticals, Inc. | Chairman | - |
Ehemalige bekannte Positionen von Frank O'Donnell
Unternehmen | Position | Ende |
---|---|---|
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Chief Executive Officer | 22.08.2005 |
INHIBITOR THERAPEUTICS, INC. | Chairman | 22.11.2016 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Chairman | 01.03.2013 |
░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ | - |
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Ausbildung von Frank O'Donnell
The Johns Hopkins University School of Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INHIBITOR THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
Laser Vision Centers, Inc.
Laser Vision Centers, Inc. Finance/Rental/LeasingFinance Laser Vision Centers, Inc.. provides a broad range of initial training of physicians and staff, technical support and equipment maintenance, marketing, clinical advisory service, patient financing, partnership opportunities, and practice satelliting. | Finance |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
RetinaPharma Technologies, Inc.
RetinaPharma Technologies, Inc. Medical DistributorsDistribution Services RetinaPharma Technologies, Inc. is a development stage biotechnology company. Its mission is to become a world leader in the prevention, diagnosis and treatment of neurologically based conditions of the retina, brain, spinal cord and peripheral nerves by offering clinically beneficial and incrementally superior drug carriers, pharmaceuticals and related devices based upon its intellectual property and proprietary technology. | Distribution Services |
Health Careers Foundation | |
Biotech Specialty Partners LLC
Biotech Specialty Partners LLC Pharmaceuticals: MajorHealth Technology Biotech Specialty Partners LLC specializes in pharmacy and biotechnology. The private company is based in Tampa, FL. The company was founded by Frank E. O'Donnell. | Health Technology |
PhotoVision Pharmaceuticals, Inc.
PhotoVision Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Photovision Pharmaceuticals, Inc. provides life sciences technology services. It offers medical instrument products. It focuses on drug development of deprenyl-based propargylamines and drug delivery carriers. The company is located in Rydal, PA. | Commercial Services |
Hopkins Capital Group
Hopkins Capital Group Investment ManagersFinance Hopkins Capital Group(Hopkins Capital) is a private equity firm founded in 1999 by Frank E. O'Donnell. The firm is headquartered in Tampa, Florida. | Finance |
Repurposed Therapeutics, Inc. | |
Defender Pharmaceuticals, Inc. |